- Investor's Business Daily•8 hours ago
Gilead will likely guide to declining 2017 sales, hamstrung on limited Hep C visibility, RBC said Wednesday.
- Moody's•12 hours ago
New York, January 18, 2017-- Moody's Investors Service commented that Biogen Inc.' s announcement that it has agreed to pay $1.25 billion to Forward Pharma related to a settlement and license agreement ...
- Zacks•15 hours agoThe Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and Berkshire Hathaway
The Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and Berkshire Hathaway
BIIB : Summary for Biogen Inc. - Yahoo Finance
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||282.87 - 286.16|
|52 Week Range||223.02 - 333.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.04|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|